{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:04:18Z","timestamp":1789589058291,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2023\/000014"],"award-info":[{"award-number":["EEQ\/2023\/000014"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.prp.2026.156402","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:04:17Z","timestamp":1770912257000},"page":"156402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Modulation of AKT\/GSK-3\u03b2 signaling by ambrisentan alleviates chronic kidney disease"],"prefix":"10.1016","volume":"281","author":[{"given":"Rohan","family":"Bhadange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-5504","authenticated-orcid":false,"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2026.156402_bib1","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S2214-109X(24)00050-0","article-title":"The major global burden of chronic kidney disease","volume":"12","author":"Jadoul","year":"2024","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"10.1016\/j.prp.2026.156402_bib2","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib4","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1038\/s41598-025-94918-x","article-title":"Cyanidin-3-glucoside upregulated NDRG2 through the PI3K\/AKT pathway to alleviate EMT and ECM in renal fibrosis","volume":"15","author":"Lu","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2026.156402_bib5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/jcm13071881","article-title":"Fibrosis in chronic kidney disease: pathophysiology and therapeutic targets","volume":"13","author":"Reiss","year":"2024","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156402_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148542","article-title":"Mesenchymal stromal cells prevent renal fibrosis in a rat model of unilateral ureteral obstruction by suppressing the renin-angiotensin system via HuR","volume":"11","author":"Gregorini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156402_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119241","article-title":"Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3\/NF-\u03baB signaling, oxidative stress and inflammation","volume":"272","author":"Hassan","year":"2021","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.prp.2026.156402_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.34067\/KID.0000000000000227","article-title":"Animal models of kidney disease: challenges and perspectives","volume":"4","author":"Liang","year":"2023","journal-title":"Kidney360"},{"issue":"20","key":"10.1016\/j.prp.2026.156402_bib9","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.3390\/jcm13206056","article-title":"Endothelin inhibitors in chronic kidney disease: new treatment prospects","volume":"13","author":"Rakotoarison","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2026.156402_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104432","article-title":"Unlocking new frontiers in kidney diseases: targeting endothelial dysfunction with emerging biomarkers and therapies","author":"Bhadange","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.prp.2026.156402_bib11","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/ijms24043427","article-title":"Endothelin receptor antagonists in kidney disease","volume":"24","author":"Mart\u00ednez-D\u00edaz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156402_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.645187","article-title":"Therapeutic insights in chronic kidney disease progression","volume":"8","author":"Shabaka","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.prp.2026.156402_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgaf002","article-title":"Repurposing the familiar: Future treatment options against chronic kidney disease","author":"Bhadange","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.prp.2026.156402_bib14","first-page":"547","article-title":"Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A\/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury","volume":"8","author":"Kaz\u0131mo\u011flu","year":"2020","journal-title":"Bratisl Lek Listy"},{"issue":"8","key":"10.1016\/j.prp.2026.156402_bib15","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1681\/ASN.2016070711","article-title":"Long-term endothelin-A receptor antagonism provides robust renal protection in humanized sickle cell disease mice","volume":"28","author":"Kasztan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prp.2026.156402_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111408","article-title":"Inhibition of p75NTR\/p53 axis by ambrisentan suppresses apoptosis and oxidative stress-mediated renal damage in a cisplatin AKI model","volume":"408","author":"Makled","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.prp.2026.156402_bib17","article-title":"Spatiotemporal delivery of multiple components of rhubarb-astragalus formula for the sysnergistic treatment of renal fibrosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156402_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118124","article-title":"Levosimendan mitigates renal fibrosis via TGF-\u03b21\/Smad axis modulation in UUO rats","volume":"187","author":"Bhadange","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2026.156402_bib19","first-page":"1","article-title":"Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA\/ROCK1 and ERK\/NF-\u03baB signaling","author":"Bhadange","year":"2025","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"issue":"17","key":"10.1016\/j.prp.2026.156402_bib20","first-page":"2575","article-title":"Ambrisentan improves the outcome of rats with liver transplantation partially through reducing nephrotoxicity","volume":"18","author":"Zhang","year":"2014","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prp.2026.156402_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122095","article-title":"Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: a potential therapeutic approach targeting TLR4-induced inflammation","volume":"332","author":"Shelke","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2026.156402_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107044","article-title":"CRISPR\/Cas9 based knockout of lncRNA MALAT1 attenuates TGF-\u03b21 induced Smad 2\/3 mediated fibrosis during AKI-to-CKD transition","author":"Puri","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156402_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfx062","article-title":"From the cover: mechanisticInsights in cytotoxic and cholestatic potential of the endothelial receptor antagonists using hepaRG cells","volume":"157","author":"Burbank","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib24","doi-asserted-by":"crossref","first-page":"15931","DOI":"10.1038\/s41598-020-72960-1","article-title":"Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis","volume":"10","author":"Kappes","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156402_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10715762.2024.2313738","article-title":"Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity","volume":"58","author":"Dagar","year":"2024","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.prp.2026.156402_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151711","article-title":"Combination of \u03b1-Klotho and telmisartan attenuates diabetic kidney disease via mitigating EMT, inflammation and apoptosis","author":"Gaikwad","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156402_bib27","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/ptr.8489","article-title":"Esculetin and Phloretin Combination Mitigates Acute Kidney Injury-Diabetes Comorbidity via Regulating Mitophagy and Inflammation: A Dual-Pronged Approach","volume":"39","author":"Dagar","year":"2025","journal-title":"Phytother Res"},{"key":"10.1016\/j.prp.2026.156402_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176676","article-title":"Wogonin ameliorates ER stress-associated inflammatory response, apoptotic death and renal fibrosis in a unilateral ureteral obstruction mouse model","volume":"977","author":"Kuo","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.prp.2026.156402_bib29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/jcm13030678","article-title":"Risk factors of chronic kidney disease progression: between old and new concepts","volume":"13","author":"Mallamaci","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.kint.2017.12.026","article-title":"Drug repurposing in kidney disease","volume":"94","author":"Panchapakesan","year":"2018","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.prp.2026.156402_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109953","article-title":"Drug repurposing opportunities for chronic kidney disease","volume":"27","author":"Chen","year":"2024","journal-title":"Iscience"},{"issue":"10","key":"10.1016\/j.prp.2026.156402_bib32","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/j.ekir.2024.07.027","article-title":"A pilot study on protective effect of ambrisentan on proteinuria in patients with alport syndrome","volume":"9","author":"Song","year":"2024","journal-title":"Kidney Int. Rep."},{"issue":"6","key":"10.1016\/j.prp.2026.156402_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1753465812458014","article-title":"An update on the use of ambrisentan in pulmonary arterial hypertension","volume":"6","author":"D\u2019Alto","year":"2012","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"9","key":"10.1016\/j.prp.2026.156402_bib34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1185\/03007995.2015.1074890","article-title":"Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review","volume":"31","author":"Peacock","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.prp.2026.156402_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.36295\/ASRO.2020.23411","article-title":"The therapeutic effects of ambrisentan on experimentally induced colitis in a male rat\u2019s models","volume":"23","author":"Atarbashe","year":"2020","journal-title":"Ann. Trop. Med. Public Health"},{"issue":"22","key":"10.1016\/j.prp.2026.156402_bib36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4254\/wjh.v8.i22.933","article-title":"Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model","volume":"8","author":"Okamoto","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.prp.2026.156402_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.lfs.2019.03.002","article-title":"Role of ambrisentan (selective endothelin-A receptor antagonist) on cigarette smoke exposure induced cognitive impairment in Danio rerio","volume":"222","author":"Muthuraman","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2026.156402_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120527","article-title":"Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-\u03b21\/Smad2\/3 and NF-kB\/NLRP3 signaling axis in mice","volume":"298","author":"Ram","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.prp.2026.156402_bib39","article-title":"Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2026.156402_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.intimp.2016.03.029","article-title":"Rutin ameliorates kidney interstitial fibrosis in rats with obstructive nephropathy","volume":"35","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.prp.2026.156402_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: a recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2026.156402_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.628519","article-title":"TGF-\u03b21 signaling: immune dynamics of chronic kidney diseases","volume":"8","author":"Tang","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12902-023-01483-3","article-title":"Acteoside protects podocyte against apoptosis through regulating AKT\/GSK-3\u03b2 signaling pathway in db\/db mice","volume":"23","author":"Li","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.prp.2026.156402_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115535","article-title":"A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1\/GSK-3\u03b2 pathway","volume":"297","author":"Yu","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib46","article-title":"Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via Akt\/GSK-3\u03b2\/Nrf2 pathway","volume":"2020","author":"Li","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2026.156402_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1538061","article-title":"Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K\/AKT pathway","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156402_bib48","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.3892\/mmr.2017.7692","article-title":"Ulinastatin inhibits renal tubular epithelial apoptosis and interstitial fibrosis in rats with unilateral ureteral obstruction","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2026.156402_bib49","first-page":"1","article-title":"Synergy of zinc oxide nanoparticles to losartan attenuates kidney injury induced by unilateral ureteral obstruction through modulation of the TNF-\u03b1\/IL6 and BAX\/BCL2 signaling pathways","author":"Khater","year":"2025","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib50","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1080\/13880209.2022.2148168","article-title":"Yiqi Huoxue Tongluo recipe regulates NR4A1 to improve renal mitochondrial function in unilateral ureteral obstruction (UUO) rats","volume":"60","author":"He","year":"2022","journal-title":"Pharm. Biol."},{"issue":"36","key":"10.1016\/j.prp.2026.156402_bib51","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.1021\/acs.jafc.3c01880","article-title":"Nephroprotective effects of cardamonin on renal ischemia reperfusion injury\/UUO-induced renal fibrosis","volume":"71","author":"Zhang","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib52","doi-asserted-by":"crossref","first-page":"44892","DOI":"10.1038\/srep44892","article-title":"Double knockout of Bax and Bak from kidney proximal tubules reduces unilateral urethral obstruction associated apoptosis and renal interstitial fibrosis","volume":"7","author":"Mei","year":"2017","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.prp.2026.156402_bib53","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-15-0364","article-title":"BCL-2 antagonism to target the intrinsic mitochondrial pathway of apoptosis","volume":"21","author":"Gibson","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156402_bib54","doi-asserted-by":"crossref","first-page":"F540","DOI":"10.1152\/ajprenal.00170.2015","article-title":"Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy","volume":"309","author":"Jang","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"182","key":"10.1016\/j.prp.2026.156402_bib55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.24976\/Discov.Med.202436182.57","article-title":"LncRNA Meg3 aggravates renal fibrosis caused by unilateral ureteral obstruction in rats by activating the hedgehog pathway","volume":"36","author":"Dong","year":"2024","journal-title":"Discov. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ptr.7599","article-title":"Quercetin inhibits the amphiregulin\/EGFR signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in obstructive nephropathy","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib57","article-title":"Noscapine alleviates unilateral ureteral obstruction-induced inflammation and fibrosis by regulating the TGF\u03b21\/Smads signaling pathways","volume":"1871","author":"Hung","year":"2024","journal-title":"Biochim. et Biophys. Acta (BBA)Mol. Cell Res."},{"issue":"9","key":"10.1016\/j.prp.2026.156402_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162186","article-title":"Alpha1-antitrypsin attenuates renal fibrosis by inhibiting TGF-\u03b21-induced epithelial mesenchymal transition","volume":"11","author":"Cho","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/0886022X.2022.2044351","article-title":"Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt\/\u03b2-catenin signaling pathway","volume":"44","author":"Feiteng","year":"2022","journal-title":"Ren. Fail."},{"key":"10.1016\/j.prp.2026.156402_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103625","article-title":"Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src\/STAT-3\/NF-\u03baB signaling","volume":"84","author":"Hassan","year":"2021","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.prp.2026.156402_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112936","article-title":"Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice","volume":"150","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7291075","article-title":"Hirudin ameliorates renal interstitial fibrosis via regulating TGF-\u03b21\/Smad and NF-\u03baB signaling in UUO rat model","volume":"2020","author":"Yang","year":"2020","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156402_bib63","article-title":"Oleanolic acid attenuates renal fibrosis through tgf-\u03b2\/smad pathway in a rat model of unilateral ureteral obstruction","volume":"2020","author":"Zhao","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:24:07Z","timestamp":1774121047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"alternative-id":["S0344033826000531"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156402","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of AKT\/GSK-3\u03b2 signaling by ambrisentan alleviates chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156402"}}